Phathom Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC PHAT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

30,631

Value ($000)

508

Weight

0.0%

2021 Q3 - 2025 Q4 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	508	0.0%	30,631	12/31/2025
2025 Q1	5/19/2025	625	0.0%	99,744	3/31/2025
2024 Q4	2/14/2025	957	0.0%	117,803	12/31/2024
2024 Q3	11/14/2024	1,772	0.0%	98,025	9/30/2024
2024 Q2	8/14/2024	959	0.0%	93,154	6/30/2024
2024 Q1	5/15/2024	137	0.0%	12,893	3/31/2024
2023 Q4	2/14/2024	118	0.0%	12,893	12/31/2023
2021 Q3	11/15/2021	241	0.0%	7,514	9/30/2021